{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T16:10:43Z","timestamp":1792426243574,"version":"4.5.0"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2014,12,9]],"date-time":"2014-12-09T00:00:00Z","timestamp":1418083200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Dig Dis Sci"],"published-print":{"date-parts":[[2015,5]]},"DOI":"10.1007\/s10620-014-3472-0","type":"journal-article","created":{"date-parts":[[2014,12,8]],"date-time":"2014-12-08T14:10:59Z","timestamp":1418047859000},"page":"1273-1283","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":48,"title":["Serum CYFRA 21-1 in Biliary Tract Cancers: A Reliable Biomarker for Gallbladder Carcinoma and Intrahepatic Cholangiocarcinoma"],"prefix":"10.1007","volume":"60","author":[{"given":"Li","family":"Huang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peiwen","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenjie","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kunsong","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shunli","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiancong","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhaohui","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bin","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuyan","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fanyin","family":"Meng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sharon","family":"DeMorrow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoyu","family":"Yin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiaming","family":"Lai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lijian","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2014,12,9]]},"reference":[{"key":"3472_CR1","doi-asserted-by":"crossref","first-page":"3531","DOI":"10.1200\/JCO.2009.27.4787","volume":"28","author":"AF Hezel","year":"2010","unstructured":"Hezel AF, Zhu AX. Genetics of biliary tract cancers and emerging targeted therapies. J Clin Oncol. 2010;28:3531\u20133540.","journal-title":"J Clin Oncol"},{"key":"3472_CR2","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1053\/j.gastro.2013.10.013","volume":"145","author":"S Rizvi","year":"2013","unstructured":"Rizvi S, Gores GJ. Pathogenesis, diagnosis, and management of cholangiocarcinoma. Gastroenterology. 2013;145:1215\u20131229.","journal-title":"Gastroenterology"},{"key":"3472_CR3","doi-asserted-by":"crossref","first-page":"e48371","DOI":"10.1371\/journal.pone.0048371","volume":"7","author":"LN Liu","year":"2012","unstructured":"Liu LN, Xu HX, Lu MD, et al. Contrast-enhanced ultrasound in the diagnosis of gallbladder diseases a multi-center experience. PLoS ONE. 2012;7:e48371.","journal-title":"PLoS ONE"},{"key":"3472_CR4","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1097\/MOG.0b013e328325a894","volume":"25","author":"D Alvaro","year":"2009","unstructured":"Alvaro D. Serum and bile biomarker for cholangiocarcinoma. Curr Opin Gastroenterol. 2009;25:279\u2013284.","journal-title":"Curr Opin Gastroenterol"},{"key":"3472_CR5","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/0092-8674(82)90400-7","volume":"31","author":"R Moll","year":"1982","unstructured":"Moll R, Franke WW, Schiller DL, Geiger B, Krepler R. The catalog of human cytokeratins: patterns of expression in normal epithelia, tumors and cultured cells. Cell. 1982;31:11\u201324.","journal-title":"Cell"},{"key":"3472_CR6","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/0009-9120(93)90129-T","volume":"26","author":"P Stieber","year":"1993","unstructured":"Stieber P, Bodenm\u00fcller H, Banauch D, et al. Cytokeratin 19 fragments: a new marker for non-small-cell lung cancer. Clin Biochem. 1993;26:301\u2013304.","journal-title":"Clin Biochem"},{"key":"3472_CR7","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1016\/0959-8049(94)90528-2","volume":"30A","author":"D Rastel","year":"1994","unstructured":"Rastel D, Ramaioli A, Cornillie F, Thirion B. CYFRA 21-1, a sensitive and specific new tumour marker for squamous cell lung cancer. Report of the first European multicentre evaluation. CYFRA 21-1 Multicentre Study Group. Eur J Cancer. 1994;30A:601\u2013606.","journal-title":"Eur J Cancer"},{"key":"3472_CR8","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1007\/s005350050112","volume":"33","author":"T Kashihara","year":"1998","unstructured":"Kashihara T, Ohki A, Kobayashi T, et al. Intrahepatic cholangiocarcinoma with increased serum CYFRA 21-1 level. J Gastroenterol. 1998;33:447\u2013453.","journal-title":"J Gastroenterol"},{"key":"3472_CR9","doi-asserted-by":"crossref","first-page":"1894","DOI":"10.1038\/sj.bjc.6601026","volume":"88","author":"T Uenishi","year":"2003","unstructured":"Uenishi T, Kubo S, Hirohashi K, et al. Cytokeratin-19 fragments in serum (CYFRA 21-1) as a marker in primary liver cancer. Br J Cancer. 2003;88:1894\u20131899.","journal-title":"Br J Cancer"},{"key":"3472_CR10","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1245\/s10434-007-9650-y","volume":"15","author":"T Uenishi","year":"2008","unstructured":"Uenishi T, Yamazaki O, Tanaka H, et al. Serum cytokeratin 19 fragment (CYFRA21-1) as a prognostic factor in intrahepatic cholangiocarcinoma. Ann Surg Oncol. 2008;15:583\u2013589.","journal-title":"Ann Surg Oncol"},{"key":"3472_CR11","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/S0973-6883(11)60110-2","volume":"1","author":"MH Chapman","year":"2011","unstructured":"Chapman MH, Sandanayake NS, Andreola F, et al. Circulating CYFRA 21-1 is a Specific Diagnostic and Prognostic Biomarker in Biliary Tract Cancer. J Clin Exp Hepatol. 2011;1:6\u201312.","journal-title":"J Clin Exp Hepatol"},{"key":"3472_CR12","unstructured":"Edge S, Byrd D, Compton C, Fritz A, Greene F, Trotti A, eds. AJCC Cancer Staging Manual. 2010."},{"key":"3472_CR13","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1002\/1097-0142(1950)3:1<32::AID-CNCR2820030106>3.0.CO;2-3","volume":"3","author":"WJ Youden","year":"1950","unstructured":"Youden WJ. Index for rating diagnostic tests. Cancer. 1950;3:32\u201335.","journal-title":"Cancer"},{"key":"3472_CR14","doi-asserted-by":"crossref","first-page":"517","DOI":"10.6028\/jres.116.003","volume":"116","author":"JC Wu","year":"2011","unstructured":"Wu JC, Martin AF, Raghu NK. Measures, uncertainties, and significance test in operational ROC analysis. J Res Natl Inst Stand Technol. 2011;116:517\u2013537.","journal-title":"J Res Natl Inst Stand Technol"},{"key":"3472_CR15","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1155\/2013\/196412","volume":"34","author":"G Malaguarnera","year":"2013","unstructured":"Malaguarnera G, Paladina I, Giordano M, Malaguarnera M, Bertino G, Berretta M. Serum markers of intrahepatic cholangiocarcinoma. Dis Markers. 2013;34:219\u2013228.","journal-title":"Dis Markers"},{"key":"3472_CR16","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1083\/jcb.200603161","volume":"174","author":"J Schweizer","year":"2006","unstructured":"Schweizer J, Bowden PE, Coulombe PA, et al. New consensus nomenclature for mammalian keratins. J Cell Biol. 2006;174:169\u2013174.","journal-title":"J Cell Biol"},{"key":"3472_CR17","first-page":"1167","volume":"149","author":"PC Wu","year":"1996","unstructured":"Wu PC, Fang JW, Lau VK, Lai CL, Lo CK, Lau JY. Classification of hepatocellular carcinoma according to hepatocellular and biliary differentiation markers. Clinical and biological implications. Am J Pathol. 1996;149:1167\u20131175.","journal-title":"Am J Pathol"},{"key":"3472_CR18","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1111\/j.1349-7006.2003.tb01366.x","volume":"94","author":"T Uenishi","year":"2003","unstructured":"Uenishi T, Kubo S, Yamamoto T, et al. Cytokeratin 19 expression in hepatocellular carcinoma predicts early postoperative recurrence. Cancer Sci. 2003;94:851\u2013857.","journal-title":"Cancer Sci"},{"key":"3472_CR19","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1074\/mcp.M300094-MCP200","volume":"3","author":"SJ Ding","year":"2004","unstructured":"Ding SJ, Li Y, Tan YX, et al. From proteomic analysis to clinical significance: overexpression of cytokeratin 19 correlates with hepatocellular carcinoma metastasis. Mol Cell Proteomics. 2004;3:73\u201381.","journal-title":"Mol Cell Proteomics"},{"key":"3472_CR20","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1007\/s00534-005-1069-x","volume":"13","author":"T Uenishi","year":"2006","unstructured":"Uenishi T, Yamazaki O, Yamamoto T, et al. Clinical significance of serum cytokeratin-19 fragment (CYFRA 21-1) in hepatocellular carcinoma. J Hepatobiliary Pancreat Surg. 2006;13:239\u2013244.","journal-title":"J Hepatobiliary Pancreat Surg"},{"key":"3472_CR21","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1002\/1097-0215(200002)9999:9999<::AID-IJC1082>3.0.CO;2-T","volume":"91","author":"K Dohmoto","year":"2001","unstructured":"Dohmoto K, Hojo S, Fujita J, et al. The role of caspase 3 in producing cytokeratin 19 fragment (CYFRA21-1) in human lung cancer cell lines. Int J Cancer. 2001;91:468\u2013473.","journal-title":"Int J Cancer"},{"key":"3472_CR22","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1038\/onc.2010.456","volume":"30","author":"V Karantza","year":"2011","unstructured":"Karantza V. Keratins in health and cancer: more than mere epithelial cell markers. Oncogene. 2011;30:127\u2013138.","journal-title":"Oncogene"},{"key":"3472_CR23","doi-asserted-by":"crossref","first-page":"R39","DOI":"10.1186\/bcr2326","volume":"11","author":"C Alix-Panabi\u00e8res","year":"2009","unstructured":"Alix-Panabi\u00e8res C, Vendrell JP, Slijper M, et al. Full-length cytokeratin-19 is released by human tumor cells a potential role in metastatic progression of breast cancer. Breast Cancer Res. 2009;11:R39.","journal-title":"Breast Cancer Res"},{"key":"3472_CR24","doi-asserted-by":"crossref","first-page":"1887","DOI":"10.1007\/s00268-011-1134-3","volume":"35","author":"D Fuks","year":"2011","unstructured":"Fuks D, Regimbeau JM, Le Treut YP, et al. Incidental gallbladder cancer by the AFC-GBC-2009 study group. World J Surg. 2011;35:1887\u20131897.","journal-title":"World J Surg"},{"key":"3472_CR25","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.1002\/cncr.11699","volume":"98","author":"WR Jarnagin","year":"2003","unstructured":"Jarnagin WR, Ruo L, Little SA, et al. Patterns of initial disease recurrence after resection of gallbladder carcinoma and hilar cholangiocarcinoma: implications for adjuvant therapeutic strategies. Cancer. 2003;98:1689\u20131700.","journal-title":"Cancer"},{"key":"3472_CR26","first-page":"2704","volume":"44","author":"AC Brabon","year":"1984","unstructured":"Brabon AC, Williams JF, Cardiff RD. A monoclonal antibody to a human breast tumor protein released in response to estrogen. Cancer Res. 1984;44:2704\u20132710.","journal-title":"Cancer Res"},{"key":"3472_CR27","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1097\/SLA.0b013e31817f2bfd","volume":"248","author":"F Ito","year":"2008","unstructured":"Ito F, Agni R, Rettammel RJ, et al. Resection of hilar cholangiocarcinoma: concomitant liver resection decreases hepatic recurrence. Ann Surg. 2008;248:273\u2013279.","journal-title":"Ann Surg"},{"key":"3472_CR28","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1097\/SLA.0b013e3181d3d2b2","volume":"251","author":"K Ito","year":"2010","unstructured":"Ito K, Ito H, Allen PJ, et al. Adequate lymph node assessment for extrahepatic bile duct adenocarcinoma. Ann Surg. 2010;251:675\u2013681.","journal-title":"Ann Surg"},{"key":"3472_CR29","first-page":"2286","volume":"122","author":"SQ Li","year":"2010","unstructured":"Li SQ, Liang LJ, Hua YP, et al. Long-term outcome and prognostic factors of intrahepatic cholangiocarcinoma. Chin Med J (Engl). 2010;122:2286\u20132291.","journal-title":"Chin Med J (Engl)"},{"key":"3472_CR30","doi-asserted-by":"crossref","first-page":"2455","DOI":"10.1007\/s10620-013-2713-y","volume":"58","author":"CH Pilgrim","year":"2013","unstructured":"Pilgrim CH, Groeschl RT, Turaga KK, Gamblin TC. Key factors influencing prognosis in relation to gallbladder cancer. Dig Dis Sci. 2013;58:2455\u20132462.","journal-title":"Dig Dis Sci"},{"key":"3472_CR31","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/S1470-2045(11)70329-1","volume":"13","author":"LH Jensen","year":"2012","unstructured":"Jensen LH. Biliary-tract cancer: improving therapy by adding molecularly targeted agents. Lancet Oncol. 2012;13:118\u2013119.","journal-title":"Lancet Oncol"}],"container-title":["Digestive Diseases and Sciences"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10620-014-3472-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10620-014-3472-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10620-014-3472-0","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,30]],"date-time":"2019-05-30T19:44:22Z","timestamp":1559245462000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10620-014-3472-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,12,9]]},"references-count":31,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2015,5]]}},"alternative-id":["3472"],"URL":"https:\/\/doi.org\/10.1007\/s10620-014-3472-0","relation":{},"ISSN":["0163-2116","1573-2568"],"issn-type":[{"value":"0163-2116","type":"print"},{"value":"1573-2568","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,12,9]]}}}